Sarah K. Emond, MPP, is the President and CEO of the Institute for Clinical and Economic Review (ICER). With 25 years of experience in healthcare policy and business, she has played a key role in expanding ICER’s influence in drug pricing and value-based healthcare. Previously, she worked in biopharmaceutical communications and clinical research. She holds a Master of Public Policy from Brandeis University and a BS in Biological Sciences from Smith College.